Tzield Sanofi-Aventis Australia Pty Ltd
Product name
Tzield
Sponsor
Accepted date
Feb-2025
Active ingredients
teplizumab
Proposed indication
To delay the onset of diabetes.
Application type
A (new medicine)
Publication date
Feb-2025